查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1349439

黄褐斑药物治疗市场（黄褐斑类型：表皮黄褐斑、真皮黄褐斑和混合黄褐斑；给药途径：口服和局部；性别：男性和女性）- 2023 年全球产业分析、规模、份额、成长、趋势和预测-2031

Melasma Drug Treatment Market (Type of Melasma: Epidermal Melasma, Dermal Melasma, and Mixed Melasma; Route of Administration: Oral and Topical; Gender: Men and Women) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 196 Pages | 商品交期: 2-10个工作天内

价格

黄褐斑药物治疗市场 - 报告范围

TMR 关于全球黄褐斑药物治疗市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球黄褐斑药物治疗的收入2017-2031年期间的市场，考虑2023年为基准年，2031年为预测年。报告中也提供了2023年至2031年全球黄褐斑药物治疗市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解黄褐斑药物治疗市场。

市场概况
2023年市场价值 26 亿美元
2031 年市场价值 52 亿美元
复合年增长率 0.083%

该报告深入探讨了全球黄褐斑药物治疗市场的竞争格局。全球黄褐斑药物治疗市场的主要参与者已经确定，并且每位参与者都根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球黄褐斑药物治疗市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2017-2031年全球市场分析与预测

第 5 章：关键见解

  • 重要行业活动
  • 疾病流行病学
  • 监管场景
  • 管道分析
  • Covid-19 影响分析

第 6 章：全球市场分析与预测：依黄褐斑类型分类

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：2017-2031年黄褐斑类型
    • 表皮黄褐斑
    • 真皮黄褐斑
    • 混合性黄褐斑
  • 市场吸引力分析：按黄褐斑类型

第 7 章：全球市场分析与预测：按给药途径

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依给药途径，2017-2031
    • 专题
    • 口服
  • 市场吸引力分析：按给药途径

第 8 章：全球市场分析与预测：依性别

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依性别，2017-2031
    • 男士
    • 女性
  • 市场吸引力分析：按性别

第 9 章：全球市场分析与预测：按药物代理商

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依药品代理商，2017-2031
    • 对苯二酚
    • 外用维A酸
    • 外用类固醇
    • 三重组合霜
    • 其他的
  • 市场吸引力分析：按药品代理商

第 10 章：全球市场分析与预测：按分销管道

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：2017-2031年按通路
    • 离线
    • 在线的
  • 市场吸引力分析：按分销管道

第 11 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第 12 章：北美市场分析与预测

第 13 章：欧洲市场分析与预测

第 14 章：亚太市场分析与预测

第 15 章：拉丁美洲市场分析与预测

第 16 章：中东和非洲市场分析与预测

第17章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司划分（2022 年）
  • 公司简介
    • AbbVie Inc.
    • GALDERMA
    • Obagi Cosmeceuticals LLC.
    • Valeant Pharmaceuticals
    • GLENMARK PHARMACEUTICALS LTD
    • Abbott
    • La Pristine
    • MESOESTETIC
Product Code: TMRGL85710

Melasma Drug Treatment Market - Scope of Report

TMR's report on the global melasma drug treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global melasma drug treatment market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global melasma drug treatment market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the melasma drug treatment market.

Market Snapshot
Market Value in 2023US$ 2.6 Bn
Market Value in 2031US$ 5.2 Bn
CAGR8.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global melasma drug treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global melasma drug treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global melasma drug treatment market.

The report delves into the competitive landscape of the global melasma drug treatment market. Key players operating in the global melasma drug treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global melasma drug treatment market profiled in this report.

Key Questions Answered in Global Melasma Drug Treatment Market Report:

  • What is the sales/revenue generated by melasma drug treatment across all regions during the forecast period?
  • What are the opportunities in the global melasma drug treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Melasma Drug Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global melasma drug treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global melasma drug treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global melasma drug treatment market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Melasma Drug Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Melasma Drug Treatment Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Key Industry Events
  • 5.2. Disease Epidemiology
  • 5.3. Regulatory Scenario
  • 5.4. Pipeline Analysis
  • 5.5. Covid-19 Impact Analysis

6. Global Melasma Drug Treatment Market Analysis and Forecast, by Type of Melasma

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Type of Melasma, 2017-2031
    • 6.3.1. Epidermal Melasma
    • 6.3.2. Dermal Melasma
    • 6.3.3. Mixed Melasma
  • 6.4. Market Attractiveness Analysis, by Type of Melasma

7. Global Melasma Drug Treatment Market Analysis and Forecast, by Route of Administration

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Route of Administration, 2017-2031
    • 7.3.1. Topical
    • 7.3.2. Oral
  • 7.4. Market Attractiveness Analysis, by Route of Administration

8. Global Melasma Drug Treatment Market Analysis and Forecast, by Gender

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Gender, 2017-2031
    • 8.3.1. Men
    • 8.3.2. Women
  • 8.4. Market Attractiveness Analysis, by Gender

9. Global Melasma Drug Treatment Market Analysis and Forecast, by Drug Agent

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by Drug Agent, 2017-2031
    • 9.3.1. Hydroquinone
    • 9.3.2. Topical Retinoid
    • 9.3.3. Topical Steroid
    • 9.3.4. Triple Combination Cream
    • 9.3.5. Others
  • 9.4. Market Attractiveness Analysis, by Drug Agent

10. Global Melasma Drug Treatment Market Analysis and Forecast, by Distribution Channel

  • 10.1. Introduction & Definition
  • 10.2. Key Findings / Developments
  • 10.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.3.1. Offline
    • 10.3.2. Online
  • 10.4. Market Attractiveness Analysis, by Distribution Channel

11. Global Melasma Drug Treatment Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast, by Region
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness Analysis, by Region

12. North America Melasma Drug Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type of Melasma, 2017-2031
    • 12.2.1. Epidermal Melasma
    • 12.2.2. Dermal Melasma
    • 12.2.3. Mixed Melasma
  • 12.3. Market Value Forecast, by Route of Administration, 2017-2031
    • 12.3.1. Topical
    • 12.3.2. Oral
  • 12.4. Market Value Forecast, by Gender, 2017-2031
    • 12.4.1. Men
    • 12.4.2. Women
  • 12.5. Market Value Forecast, by Drug Agent, 2017-2031
    • 12.5.1. Hydroquinone
    • 12.5.2. Topical Retinoid
    • 12.5.3. Topical Steroid
    • 12.5.4. Triple Combination Cream
    • 12.5.5. Others
  • 12.6. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.6.1. Offline
    • 12.6.2. Online
  • 12.7. Market Value Forecast, by Country, 2017-2031
    • 12.7.1. U.S.
    • 12.7.2. Canada
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Type of Melasma
    • 12.8.2. By Route of Administration
    • 12.8.3. By Gender
    • 12.8.4. By Drug Agent
    • 12.8.5. By Distribution Channel
    • 12.8.6. By Country

13. Europe Melasma Drug Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type of Melasma, 2017-2031
    • 13.2.1. Epidermal Melasma
    • 13.2.2. Dermal Melasma
    • 13.2.3. Mixed Melasma
  • 13.3. Market Value Forecast, by Route of Administration, 2017-2031
    • 13.3.1. Topical
    • 13.3.2. Oral
  • 13.4. Market Value Forecast, by Gender, 2017-2031
    • 13.4.1. Men
    • 13.4.2. Women
  • 13.5. Market Value Forecast, by Drug Agent, 2017-2031
    • 13.5.1. Hydroquinone
    • 13.5.2. Topical Retinoid
    • 13.5.3. Topical Steroid
    • 13.5.4. Triple Combination Cream
    • 13.5.5. Others
  • 13.6. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.6.1. Offline
    • 13.6.2. Online
  • 13.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.7.1. U.K.
    • 13.7.2. Germany
    • 13.7.3. France
    • 13.7.4. Spain
    • 13.7.5. Italy
    • 13.7.6. Rest of Europe
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Type of Melasma
    • 13.8.2. By Route of Administration
    • 13.8.3. By Gender
    • 13.8.4. By Drug Agent
    • 13.8.5. By Distribution Channel
    • 13.8.6. By Country/Sub-region

14. Asia Pacific Melasma Drug Treatment Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type of Melasma, 2017-2031
    • 14.2.1. Epidermal Melasma
    • 14.2.2. Dermal Melasma
    • 14.2.3. Mixed Melasma
  • 14.3. Market Value Forecast, by Route of Administration, 2017-2031
    • 14.3.1. Topical
    • 14.3.2. Oral
  • 14.4. Market Value Forecast, by Gender, 2017-2031
    • 14.4.1. Men
    • 14.4.2. Women
  • 14.5. Market Value Forecast, by Drug Agent, 2017-2031
    • 14.5.1. Hydroquinone
    • 14.5.2. Topical Retinoid
    • 14.5.3. Topical Steroid
    • 14.5.4. Triple Combination Cream
    • 14.5.5. Others
  • 14.6. Market Value Forecast, by Distribution Channel, 2017-2031
    • 14.6.1. Offline
    • 14.6.2. Online
  • 14.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.7.1. China
    • 14.7.2. Japan
    • 14.7.3. India
    • 14.7.4. Australia & New Zealand
    • 14.7.5. Rest of Asia Pacific
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Type of Melasma
    • 14.8.2. By Route of Administration
    • 14.8.3. By Gender
    • 14.8.4. By Drug Agent
    • 14.8.5. By Distribution Channel
    • 14.8.6. By Country/Sub-region

15. Latin America Melasma Drug Treatment Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Type of Melasma, 2017-2031
    • 15.2.1. Epidermal Melasma
    • 15.2.2. Dermal Melasma
    • 15.2.3. Mixed Melasma
  • 15.3. Market Value Forecast, by Route of Administration, 2017-2031
    • 15.3.1. Topical
    • 15.3.2. Oral
  • 15.4. Market Value Forecast, by Gender, 2017-2031
    • 15.4.1. Men
    • 15.4.2. Women
  • 15.5. Market Value Forecast, by Drug Agent, 2017-2031
    • 15.5.1. Hydroquinone
    • 15.5.2. Topical Retinoid
    • 15.5.3. Topical Steroid
    • 15.5.4. Triple Combination Cream
    • 15.5.5. Others
  • 15.6. Market Value Forecast, by Distribution Channel, 2017-2031
    • 15.6.1. Offline
    • 15.6.2. Online
  • 15.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.7.1. Brazil
    • 15.7.2. Mexico
    • 15.7.3. Rest of Latin America
  • 15.8. Market Attractiveness Analysis
    • 15.8.1. By Type of Melasma
    • 15.8.2. By Route of Administration
    • 15.8.3. By Gender
    • 15.8.4. By Drug Agent
    • 15.8.5. By Distribution Channel
    • 15.8.6. By Country/Sub-region

16. Middle East & Africa Melasma Drug Treatment Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast, by Type of Melasma, 2017-2031
    • 16.2.1. Epidermal Melasma
    • 16.2.2. Dermal Melasma
    • 16.2.3. Mixed Melasma
  • 16.3. Market Value Forecast, by Route of Administration, 2017-2031
    • 16.3.1. Topical
    • 16.3.2. Oral
  • 16.4. Market Value Forecast, by Gender, 2017-2031
    • 16.4.1. Men
    • 16.4.2. Women
  • 16.5. Market Value Forecast, by Drug Agent, 2017-2031
    • 16.5.1. Hydroquinone
    • 16.5.2. Topical Retinoid
    • 16.5.3. Topical Steroid
    • 16.5.4. Triple Combination Cream
    • 16.5.5. Others
  • 16.6. Market Value Forecast, by Distribution Channel, 2017-2031
    • 16.6.1. Offline
    • 16.6.2. Online
  • 16.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 16.7.1. GCC Countries
    • 16.7.2. South Africa
    • 16.7.3. Rest of Middle East & Africa
  • 16.8. Market Attractiveness Analysis
    • 16.8.1. By Type of Melasma
    • 16.8.2. By Route of Administration
    • 16.8.3. By Gender
    • 16.8.4. By Drug Agent
    • 16.8.5. By Distribution Channel
    • 16.8.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (by tier and size of companies)
  • 17.2. Market Share Analysis, by Company (2022)
  • 17.3. Company Profiles
    • 17.3.1. AbbVie Inc.
      • 17.3.1.1. Company Overview
      • 17.3.1.2. Financial Overview
      • 17.3.1.3. Product Portfolio
      • 17.3.1.4. Business Strategies
      • 17.3.1.5. Recent Developments
    • 17.3.2. GALDERMA
      • 17.3.2.1. Company Overview
      • 17.3.2.2. Financial Overview
      • 17.3.2.3. Product Portfolio
      • 17.3.2.4. Business Strategies
      • 17.3.2.5. Recent Developments
    • 17.3.3. Obagi Cosmeceuticals LLC.
      • 17.3.3.1. Company Overview
      • 17.3.3.2. Financial Overview
      • 17.3.3.3. Product Portfolio
      • 17.3.3.4. Business Strategies
      • 17.3.3.5. Recent Developments
    • 17.3.4. Valeant Pharmaceuticals
      • 17.3.4.1. Company Overview
      • 17.3.4.2. Financial Overview
      • 17.3.4.3. Product Portfolio
      • 17.3.4.4. Business Strategies
      • 17.3.4.5. Recent Developments
    • 17.3.5. GLENMARK PHARMACEUTICALS LTD
      • 17.3.5.1. Company Overview
      • 17.3.5.2. Financial Overview
      • 17.3.5.3. Product Portfolio
      • 17.3.5.4. Business Strategies
      • 17.3.5.5. Recent Developments
    • 17.3.6. Abbott
      • 17.3.6.1. Company Overview
      • 17.3.6.2. Financial Overview
      • 17.3.6.3. Product Portfolio
      • 17.3.6.4. Business Strategies
      • 17.3.6.5. Recent Developments
    • 17.3.7. La Pristine
      • 17.3.7.1. Company Overview
      • 17.3.7.2. Financial Overview
      • 17.3.7.3. Product Portfolio
      • 17.3.7.4. Business Strategies
      • 17.3.7.5. Recent Developments
    • 17.3.8. MESOESTETIC
      • 17.3.8.1. Company Overview
      • 17.3.8.2. Financial Overview
      • 17.3.8.3. Product Portfolio
      • 17.3.8.4. Business Strategies
      • 17.3.8.5. Recent Developments

List of Tables

  • Table 01: Global Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Type of Melasma, 2017-2031
  • Table 02: Global Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 03: Global Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Drug Agent, 2017-2031
  • Table 04: Global Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Gender, 2017-2031
  • Table 05: Global Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 06: Global Melasma Drug Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 07: North America Melasma Drug Treatment Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 08: North America Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Type of Melasma, 2017-2031
  • Table 09: North America Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 10: North America Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Drug Agent, 2017-2031
  • Table 11: North America Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Gender, 2017-2031
  • Table 12: North America Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 13: Europe Melasma Drug Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Europe Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Type of Melasma, 2017-2031
  • Table 15: Europe Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 16: Europe Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Drug Agent, 2017-2031
  • Table 17: Europe Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Gender, 2017-2031
  • Table 18: Europe Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 19: Asia Pacific Melasma Drug Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 20: Asia Pacific Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Type of Melasma, 2017-2031
  • Table 21: Asia Pacific Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 22: Asia Pacific Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Drug Agent, 2017-2031
  • Table 23: Asia Pacific Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Gender, 2017-2031
  • Table 24: Asia Pacific Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 25: Latin America Melasma Drug Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Latin America Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Type of Melasma, 2017-2031
  • Table 27: Latin America Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 28: Latin America Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Drug Agent, 2017-2031
  • Table 29: Latin America Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Gender, 2017-2031
  • Table 30: Latin America Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 31: Middle East and Africa Melasma Drug Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 32: Middle East and Africa Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Type of Melasma, 2017-2031
  • Table 33: Middle East and Africa Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 34: Middle East and Africa Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Drug Agent, 2017-2031
  • Table 35: Middle East and Africa Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Gender, 2017-2031
  • Table 36: Middle East and Africa Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031

List of Figures

  • Figure 01: Global Melasma Drug Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Melasma Drug Treatment Market Value Share, by Type of Melasma, 2022
  • Figure 03: Global Melasma Drug Treatment Market Value Share, by Route of Administration 2022
  • Figure 04: Global Melasma Drug Treatment Market Value Share, by Drug Agent, 2022
  • Figure 05: Global Melasma Drug Treatment Market Value Share, by Route of Administration, 2022
  • Figure 06: Global Melasma Drug Treatment Market Value Share, by Distribution Channel, 2022
  • Figure 07: Global Melasma Drug Treatment Market Value Share Analysis, by Type of Melasma, 2022 and 2031
  • Figure 08: Global Melasma Drug Treatment Market Revenue (US$ Mn), by Epidermal Melasma, 2017-2031
  • Figure 09: Global Melasma Drug Treatment Market Value Share Analysis, by Dermal Melasma, 2022 and 2031
  • Figure 10: Global Melasma Drug Treatment Market Revenue (US$ Mn), by Mixed Plasma, 2017-2031
  • Figure 11: Global Melasma Drug Treatment Market Attractiveness Analysis, by Type of Melasma, 2023-2031
  • Figure 12: Global Melasma Drug Treatment Market Value Share Analysis, by Route of Administration 2022 and 2031
  • Figure 13: Global Melasma Drug Treatment Market Revenue (US$ Mn), by Topical, 2017-2031
  • Figure 14: Global Melasma Drug Treatment Market Revenue (US$ Mn), by Oral 2017-2031
  • Figure 15: Global Melasma Drug Treatment Market Attractiveness Analysis, by Route of Administration 2023-2031
  • Figure 16: Global Melasma Drug Treatment Market Value Share Analysis, by Drug Agent, 2022 and 2031
  • Figure 17: Global Melasma Drug Treatment Market Revenue (US$ Mn), by Hydroquinone, 2017-2031
  • Figure 18: Global Melasma Drug Treatment Market Revenue (US$ Mn), by Topical Retinoid, 2017-2031
  • Figure 19: Global Melasma Drug Treatment Market Revenue (US$ Mn), by Topical Steroid, 2017-2031
  • Figure 20: Global Melasma Drug Treatment Market Revenue (US$ Mn), by Triple Combination Cream, 2017-2031
  • Figure 21: Global Melasma Drug Treatment Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 22: Global Melasma Drug Treatment Market Attractiveness Analysis, by Drug Agent, 2023-2031
  • Figure 23: Global Melasma Drug Treatment Market Value Share Analysis, by Gender, 2022 and 2031
  • Figure 24: Global Melasma Drug Treatment Market Revenue (US$ Mn), by Men, 2017-2031
  • Figure 25: Global Melasma Drug Treatment Market Revenue (US$ Mn), by Women, 2017-2031
  • Figure 26: Global Melasma Drug Treatment Market Attractiveness Analysis, by Gender, 2023-2031
  • Figure 27: Global Melasma Drug Treatment Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 28: Global Melasma Drug Treatment Market Revenue (US$ Mn), by Offline, 2017-2031
  • Figure 29: Global Melasma Drug Treatment Market Revenue (US$ Mn), by Online, 2017-2031
  • Figure 30: Global Melasma Drug Treatment Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 31: Global Melasma Drug Treatment Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 32: Global Melasma Drug Treatment Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 33: North America Melasma Drug Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 34: North America Melasma Drug Treatment Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 35: North America Melasma Drug Treatment Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 36: North America Melasma Drug Treatment Market Value Share Analysis, by Type of Melasma, 2022 and 2031
  • Figure 37: North America Melasma Drug Treatment Market Attractiveness Analysis, by Type of Melasma, 2023-2031
  • Figure 38: North America Melasma Drug Treatment Market Value Share Analysis, by Drug Agent, 2022 and 2031
  • Figure 39: North America Melasma Drug Treatment Market Attractiveness Analysis, by Drug Agent, 2023-2031
  • Figure 40: North America Melasma Drug Treatment Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 41: North America Melasma Drug Treatment Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 42: North America Melasma Drug Treatment Market Value Share Analysis, by Gender, 2022 and 2031
  • Figure 43: North America Melasma Drug Treatment Market Attractiveness Analysis, by Gender, 2023-2031
  • Figure 44: North America Melasma Drug Treatment Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 45: North America Melasma Drug Treatment Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 46: Europe Melasma Drug Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 47: Europe Melasma Drug Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 48: Europe Melasma Drug Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 49: Europe Melasma Drug Treatment Market Value Share Analysis, by Type of Melasma, 2022 and 2031
  • Figure 50: Europe Melasma Drug Treatment Market Attractiveness Analysis, by Type of Melasma, 2023-2031
  • Figure 51: Europe Melasma Drug Treatment Market Value Share Analysis, by Drug Agent, 2022 and 2031
  • Figure 52: Europe Melasma Drug Treatment Market Attractiveness Analysis, by Drug Agent, 2023-2031
  • Figure 53: Europe Melasma Drug Treatment Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 54: Europe Melasma Drug Treatment Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 55: Europe Melasma Drug Treatment Market Value Share Analysis, by Gender, 2022 and 2031
  • Figure 56: Europe Melasma Drug Treatment Market Attractiveness Analysis, by Gender, 2023-2031
  • Figure 57: Europe Melasma Drug Treatment Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 58: Europe Melasma Drug Treatment Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 59: Asia Pacific Melasma Drug Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 60: Asia Pacific Melasma Drug Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 61: Asia Pacific Melasma Drug Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 62: Asia Pacific Melasma Drug Treatment Market Value Share Analysis, by Type of Melasma, 2022 and 2031
  • Figure 63: Asia Pacific Melasma Drug Treatment Market Attractiveness Analysis, by Type of Melasma, 2023-2031
  • Figure 64: Asia Pacific Melasma Drug Treatment Market Value Share Analysis, by Drug Agent, 2022 and 2031
  • Figure 65: Asia Pacific Melasma Drug Treatment Market Attractiveness Analysis, by Drug Agent, 2023-2031
  • Figure 66: Asia Pacific Melasma Drug Treatment Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 67: Asia Pacific Melasma Drug Treatment Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 68: Asia Pacific Melasma Drug Treatment Market Value Share Analysis, by Gender, 2022 and 2031
  • Figure 69: Asia Pacific Melasma Drug Treatment Market Attractiveness Analysis, by Gender, 2023-2031
  • Figure 70: Asia Pacific Melasma Drug Treatment Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 71: Asia Pacific Melasma Drug Treatment Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 72: Latin America Melasma Drug Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 73: Latin America Melasma Drug Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 74: Latin America Melasma Drug Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 75: Latin America Melasma Drug Treatment Market Value Share Analysis, by Type of Melasma, 2022 and 2031
  • Figure 76: Latin America Melasma Drug Treatment Market Attractiveness Analysis, by Type of Melasma, 2023-2031
  • Figure 77: Latin America Melasma Drug Treatment Market Value Share Analysis, by Drug Agent, 2022 and 2031
  • Figure 78: Latin America Melasma Drug Treatment Market Attractiveness Analysis, by Drug Agent, 2023-2031
  • Figure 79: Latin America Melasma Drug Treatment Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 80: Latin America Melasma Drug Treatment Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 81: Latin America Melasma Drug Treatment Market Value Share Analysis, by Gender, 2022 and 2031
  • Figure 82: Latin America Melasma Drug Treatment Market Attractiveness Analysis, by Gender, 2023-2031
  • Figure 83: Latin America Melasma Drug Treatment Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 84: Latin America Melasma Drug Treatment Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 85: Middle East and Africa Melasma Drug Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 86: Middle East and Africa Melasma Drug Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 87: Middle East and Africa Melasma Drug Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 88: Middle East and Africa Melasma Drug Treatment Market Value Share Analysis, by Type of Melasma, 2022 and 2031
  • Figure 89: Middle East and Africa Melasma Drug Treatment Market Attractiveness Analysis, by Type of Melasma, 2023-2031
  • Figure 90: Middle East and Africa Melasma Drug Treatment Market Value Share Analysis, by Drug Agent, 2022 and 2031
  • Figure 91: Middle East and Africa Melasma Drug Treatment Market Attractiveness Analysis, by Drug Agent, 2023-2031
  • Figure 92: Middle East and Africa Melasma Drug Treatment Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 93: Middle East and Africa Melasma Drug Treatment Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 94: Middle East and Africa Melasma Drug Treatment Market Value Share Analysis, by Gender, 2022 and 2031
  • Figure 95: Middle East and Africa Melasma Drug Treatment Market Attractiveness Analysis, by Gender, 2023-2031
  • Figure 96: Middle East and Africa Melasma Drug Treatment Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 97: Middle East and Africa Melasma Drug Treatment Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 98: Company Share Analysis